MiniMed Group, Inc. (MMEDV) vs Nuvectis Pharma, Inc. (NVCT)
A side-by-side comparison of MiniMed Group, Inc. and Nuvectis Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MMEDV
MiniMed Group, Inc.
$20.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
NVCT
Nuvectis Pharma, Inc.
$20.36HealthcareDelayed quote: Oct 6, 2026, 12:53 PM EDT
Total return — MMEDV vs NVCT
growth of $100 · dividends reinvested · last 1yMMEDV +7.0% (+7.0%/yr)NVCT -2.4% (-2.4%/yr)MMEDV compounded faster over this window
MMEDV NVCT
Metrics side by side
Total return (annualized)
| Metric | MMEDV | NVCT |
|---|---|---|
| Total return (1Y) | N/A | 253.76% |
| Total return CAGR (3Y) | N/A | 25.31% |
MMEDV is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.